ARTICLE | Company News
Cephalon, Mepha deal
April 19, 2010 7:00 AM UTC
Cephalon completed its previously announced acquisition of generics company Mepha for CHF662.4 million ($623.4 million) in cash. Mepha will become a wholly owned subsidiary of Cephalon (see BioCentury...